The effect of phenothiazines on botulinus intoxication.
D000818:Animals; D000992:Antitoxins / Q000627:therapeutic use; D001097:Arachnida; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001905:Botulinum Toxins; D001906:Botulism / Q000188:drug therapy*; D002090:Butyrophenones / Q000009:adverse effects / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D008297:Male; D010546:Perphenazine / Q000627:therapeutic use; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D014118:Toxins, Biological / Q000627:therapeutic use*; D014268:Trifluoperazine / Q000627:therapeutic use
D000992:Antitoxins; D002090:Butyrophenones; D010640:Phenothiazines; D014118:Toxins, Biological; D014268:Trifluoperazine; D001905:Botulinum Toxins; D010546:Perphenazine; D006220:Haloperidol; D005476:Fluphenazine